对《用于突变型KRAS癌症治疗的小分子KRAS激动剂》的更正
Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy.
作者信息
Xu Ke, Park Dongkyoo, Magis Andrew T, Zhang Jun, Zhou Wei, Sica Gabriel L, Ramalingam Suresh S, Curran Walter J, Deng Xingming
机构信息
Division of Cancer Biology, Department of Radiation Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, GA, 30322, USA.
Institute for Systems Biology, Seattle, WA, 98109, USA.
出版信息
Mol Cancer. 2020 May 20;19(1):93. doi: 10.1186/s12943-020-01214-5.
Abstract
An amendment to this paper has been published and can be accessed via the original article.
摘要
本文的一个修订版本已发表，可通过原始文章获取。
相似文献
1
Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy.对《用于突变型KRAS癌症治疗的小分子KRAS激动剂》的更正
Mol Cancer. 2020 May 20;19(1):93. doi: 10.1186/s12943-020-01214-5.
2
Correction: Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer.更正：抑制干扰素基因表达可克服KRAS突变型结直肠癌对MEK抑制的耐药性。
Oncogene. 2019 Jul;38(28):5746. doi: 10.1038/s41388-019-0835-1.
3
Correction to: A pilot study of improved psychological distress with art therapy in patients with cancer undergoing chemotherapy.对《艺术疗法改善化疗期癌症患者心理困扰的初步研究》的更正
BMC Cancer. 2020 Nov 20;20(1):1125. doi: 10.1186/s12885-020-07643-1.
4
Correction to: microRNA-124 inhibits bone metastasis of breast cancer by repressing Interleukin-11.对《微小RNA-124通过抑制白细胞介素-11抑制乳腺癌骨转移》的更正
Mol Cancer. 2020 Jun 27;19(1):111. doi: 10.1186/s12943-020-01226-1.
5
Correction to: Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer.对《辅助同步放化疗与单纯化疗治疗可切除胆管癌的疗效比较》一文的更正
BMC Gastroenterol. 2020 Jul 2;20(1):207. doi: 10.1186/s12876-020-01347-3.
6
Correction to: Downregulation of GLYR1 contributes to microsatellite instability colorectal cancer by targeting p21 via the p38MAPK and PI3K/AKT pathways.对以下内容的更正：GLYR1的下调通过p38MAPK和PI3K/AKT途径靶向p21，从而导致微卫星不稳定型结直肠癌。
J Exp Clin Cancer Res. 2020 Jul 6;39(1):125. doi: 10.1186/s13046-020-01635-6.
7
Correction to: Recent advances in Surface Guided Radiation Therapy.对《表面引导放射治疗的最新进展》的修正
Radiat Oncol. 2020 Oct 24;15(1):244. doi: 10.1186/s13014-020-01661-w.
8
Correction to: SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway.对《SNCG通过靶向PI3K/AKT信号通路促进高级别浆液性卵巢癌的进展和转移》的更正
J Exp Clin Cancer Res. 2020 Jun 17;39(1):115. doi: 10.1186/s13046-020-01596-w.
9
Correction to: Circular RNA profiling and its potential for esophageal squamous cell cancer diagnosis and prognosis.对《环状RNA分析及其在食管鳞状细胞癌诊断和预后中的潜力》的更正
Mol Cancer. 2020 Jul 2;19(1):113. doi: 10.1186/s12943-020-01230-5.
10
Correction to: The majority of β-catenin mutations in colorectal cancer is homozygous.对《结直肠癌中大多数β-连环蛋白突变是纯合的》的更正
BMC Cancer. 2020 Nov 26;20(1):1151. doi: 10.1186/s12885-020-07645-z.
引用本文的文献
1
Thermal Shift Assay for Small GTPase Stability Screening: Evaluation and Suitability.热迁移分析用于小 GTPase 稳定性筛选：评估和适用性。
Int J Mol Sci. 2022 Jun 26;23(13):7095. doi: 10.3390/ijms23137095.
本文引用的文献
1
Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy.小分子 KRAS 激动剂用于突变 KRAS 癌症治疗。
Mol Cancer. 2019 Apr 10;18(1):85. doi: 10.1186/s12943-019-1012-4.
Zotero 插件